Reimagining Antibody Drug Discovery with AI
October 27, 2025
By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.
6 min read
False
October 27, 2025
By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.
6 min read
By Stephanie Vine
October 24, 2025
We speak with a biotech CEO about the potential of psychedelic medicine – and the challenges of working with stigmatized substances.
11 min read
October 17, 2025
Quarraisha Abdool Karim discusses COVID-19 and why the industry must continue to invest in mRNA – and take the public along with them
11 min read
October 8, 2025
How military training and a fascination for nature have combined to build a sustainable business.
6 min read
By Rob Coker
October 7, 2025
Centuries of healing wisdom meet AI and molecular modeling, opening new possibilities for pharma pipelines.
2 min read
By Stephanie Vine
October 6, 2025
Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.
7 min read
October 2, 2025
UPenn researchers use AI to discover thousands of potential new antibiotics from ancient microbes.
2 min read
September 25, 2025
From unstable molecules to unpredictable pharmacokinetics, peptide drugs have faced more than their share of obstacles. Now, researchers are pairing AI with high-throughput chemistry to rethink how these medicines are discovered.
3 min read
September 24, 2025
Researchers from the University of Birmingham examine the effects of psychedelic drugs on the immune system – but are they trippin’?
3 min read
By Stavroula Ntoufa
September 18, 2025
From bridging fragmented information to overcoming research bias; here’s how AI is making an impact in research.
4 min read
False
False
False